仝小林教授从络病论治糖尿病周围神经病变

张海宇; 刘文科

doi:10.19664/j.cnki.1002-2392.220178

意见反馈

您当前的位置：

首页 >

文章列表页 >

仝小林教授从络病论治糖尿病周围神经病变

中国中医药临床案例成果库 | 临证经验

上一篇: 无

下一篇: 王国才教授从血瘀论治不寐经验总结

仝小林教授从络病论治糖尿病周围神经病变
Treating DPN Based on Collateral Diseases by Professor TONG Xiaolin
1.中国中医科学院广安门医院，北京　100053
DOI：10.19664/j.cnki.1002-2392.220178

扫描看全文

张海宇, 刘文科. 仝小林教授从络病论治糖尿病周围神经病变[DB/OL].（2023-08-01）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.19664/j.cnki.1002-2392.220178

ZHANG Haiyu, LIU Wenke. Treating DPN Based on Collateral Diseases by Professor TONG Xiaolin[DB/OL].（2023-08-01）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.19664/j.cnki.1002-2392.220178
张海宇, 刘文科. 仝小林教授从络病论治糖尿病周围神经病变[DB/OL].（2023-08-01）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.19664/j.cnki.1002-2392.220178 DOI：

ZHANG Haiyu, LIU Wenke. Treating DPN Based on Collateral Diseases by Professor TONG Xiaolin[DB/OL].（2023-08-01）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.19664/j.cnki.1002-2392.220178 DOI：

摘要

糖尿病周围神经病变是糖尿病最常见的慢性并发症之一，仝小林教授将其归为“糖络病”范畴，认为糖尿病周围神经病变属于糖尿病“虚、损”阶段，其或起于“消瘅”，或源于“脾瘅”，最终导致络脉瘀损而出现周围神经病变。依据络病程度分期，即早期络滞，中期络瘀，晚期络闭、络损，期下分证。治当整体调态，全程治络，辨证选方，随症加减。

Abstract

Diabetic peripheral neuropathy(DPN)is one of the most common chronic complications of diabetes mellitus(DM). Professor TONG Xiaolin classified DPN as ‘blood glucose collateral disease’ and thought it was in the ‘deficiency and damage’ stage of DM. It may originate from ‘Xiao Dan’or ‘Pi Dan’, which eventually leads to peripheral neuropathy due to collateral stasis. According to the degree of collateral disease, DPN is divided into early collateral stasis, midterm collateral stasis, late collateral closure and collateral damage, which guides syndrome differentiation by stages. The treatment of DPN should be adjusted as a whole, treat the collateral throughout the whole process, select the prescription based on syndrome differentiation and modify the prescription according to clinical symptoms.

关键词

糖尿病周围神经病变络病分期辨证仝小林

Keywords

Diabetic peripheral neuropathyCollateral DiseaseStage differentiationTONG Xiaolin

references

FELDMAN E L, CALLAGHAN B C, POP-BUSUI R, et al. Diabetic neuropathy[J]. Nat Rev Dis Primers, 2019, 5(1):41-59.

王秀阁, 倪青, 庞国明.糖尿病周围神经病变病证结合诊疗指南[J]. 中医杂志.2021, 62(18):1648-1656.

SOBHANI S, ASAYESH H, SHARIFI F, et al. Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis[J]. J Diabetes Metab Disord, 2014, 13(1):97-104.

TADESSE D B, GEBREWAHD G T, HAILAY A, et al. Diabetic peripheral neuropathy in ethiopia: a systematic review and meta-analysis[J]. J Diabetes Res, 2021, 2021:5304124.

SHIFERAW W S, AKALU T Y, WORK Y, et al. Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis[J]. BMC Endocr Disord, 2020, 20(1):49-58.

MORRISON S, COLBERG S R, PARSON H K, et al. Relation between risk of falling and postural sway complexity in diabetes[J]. Gait Posture, 2012, 35(4):662-668.

LECHLEITNER M, ABRAHAMIAN H, FRANCESCONI C, et al. Diabetic neuropathy and diabetic foot syndrome(update 2019)[J]. Wien Klin Wochenschr, 2019, 131(suppl 1):141-150.

CALLAGHAN B C, CHENG H T, STABLES C L, et al. Diabetic neuropathy: clinical manifestations and current treatments[J]. Lancet Neurol, 2012, 11(6):521-534.

BURSAC S N, JANDRIC S, TALIC G. Influence of diabetic distal symmetric polyneuropathy on the performance of the musculoskeletal system of lower leg and foot[J]. Med Arch, 2019, 73(4):262-267.

CALLAGHAN B C, LITTLE A A, FELDMAN E L, et al. Enhanced glucose control for preventing and treating diabetic neuropathy[J]. Cochrane Database Syst Rev, 2012, 6(6): CD007543.

SATOH J, YAGIHASHI S, BABA M, et al. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial[J]. Diabet Med, 2011, 28(1):109-116.

ZIEGLER D, LOW P A, LITCHY W J, et al. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial[J]. Diabetes Care, 2011, 34(9):2054-2060.

古玉梅.糖尿病周围神经病变的中医证候分布及其相关性研究[D]. 广州: 广州中医药大学, 2018.

刘文科, 倪青.论脾瘅理论与三型辨证[J]. 北京中医药, 2017, 36(6):516-518.

赵锡艳, 余秋平, 刘阳, 等.仝小林辨治糖尿病周围神经病变经验[J]. 中医杂志, 2013, 54(10):882-883.

杨帆.30例中重度痛性糖尿病周围神经病变的回顾性分析及“糖络同治”思想浅析[D]. 北京: 北京中医药大学, 2018.

仝小林, 赵昱, 毕桂芝, 等.试论中医“治未病”及“络病”理论在糖尿病微血管并发症治疗中的应用[J]. 中医杂志, 2007, 48(6):485-486,494.

仝小林, 胡洁, 李洪皎, 等.糖尿病中医新论[J]. 中华中医药杂志, 2006, 21(6):349-352.

仝小林.黄芪桂枝五物汤治疗糖尿病周围神经病变[J]. 中国乡村医药, 2011, 18(1):10-11.

朴春丽, 罗金丽, 刘文科.态靶辨证在气虚络瘀型糖尿病周围神经病变中的运用——黄芪桂枝五物汤加川乌、鸡血藤、桑枝[J]. 辽宁中医杂志, 2020, 47(2):4-6.

王涵, 周强, 仝小林.仝小林治疗糖尿病并发症应用黄芪经验[J]. 环球中医药, 2013, 6(4):272-274.

姬航宇.《伤寒论》本源药物剂量探索[D]. 北京: 北京中医药大学, 2009.

刘萍.芍药、白芍、赤芍的历代本草考证浅析[J]. 中华中医药杂志, 2018, 33(12):5662-5665.

李鹏.生姜、大枣配伍功效浅析[J]. 中医学报, 2018, 33(1):119-121.

秦双双, 朱艳霞, 韦坤华, 等.鸡血藤的本草沿革与黄酮类成分及其药理学研究进展[J]. 中国中药杂志, 2018, 43(11):2216-2223.

赵生慧, 金德, 安学冬, 等.黄芪、川桂枝、鸡血藤治疗糖尿病周围神经病变经验——仝小林三味小方撷萃[J]. 吉林中医药, 2020, 40(9):1131-1133.

顾成娟, 朴春丽, 吴学敏, 等.降香、水蛭、川芎治疗微循环障碍经验——仝小林三味小方撷萃[J]. 吉林中医药, 2019, 39(11):1466-1468.

王涵, 顾成娟, 仝小林.桑叶、桑枝、桑白皮治疗糖尿病经验——仝小林三味小方撷萃[J]. 吉林中医药, 2019, 39(11):1463-1465.

赵锡艳, 王松, 刘阳, 等.仝小林教授应用煅龙牡用量策略41例的回顾性分析[J]. 世界中西医结合杂志, 2013, 8(4):334-335.

罗金丽, 顾成娟, 赵林华.夜明砂、晚蚕砂、五灵脂调整肠道菌群经验——仝小林三味小方撷萃[J]. 吉林中医药, 2020, 40(1):8-11.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

仝小林院士治疗甲巯咪唑过敏甲状腺功能亢进症验案1例

从气血理论探讨糖尿病高危足的中医治疗

仝小林院士治疗糖尿病肾脏疾病大量白蛋白尿期验案1例

仝小林院士辨治新型冠状病毒肺炎

仝小林院士“态靶因果”理论辨治成人1型脆性糖尿病伴多系统并发症验案